We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Article |

Psychopharmacology Frontiers: Second International Congress of Psychiatry, Proceedings of the Psychopharmacology Symposium, [held in Zurich, Switzerland on September 2-4, 1957]

JAMA. 1959;170(7):884. doi:10.1001/jama.1959.03010070124029.
Text Size: A A A
Published online


The publication of symposiums provides the interested reader with information which could not be obtained from a single author. This book contains the views of the world's leading authorities in the field of effective drug therapy in mental disease. The chapters are short, concise, and contain a minimum but necessary amount of statistical data. The large number of chapters results in a moderate amount of repetition, but this is an indication of general agreement. The progressive trend toward the pharmacological management of disturbed patients and away from the more traumatic methods used in the past should prove encouraging to the reader. The values of available drugs are described, as well as their limitations. An important contribution is the graphic description of the multitude of toxic reactions and side-effects that may occur with the clinical use of the phenothiazine and reserpinelike derivatives. Chapters on postulated modes of action of the drugs


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview




Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.